E-LIB Suche - Ergebnisse für: Ceribelli, Michele

1

Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-2..:

Arakawa, Yasuhiro ; Jo, Ukhyun ; Kumar, Suresh...
Cancer Research Communications. 4 (2024) 3 - p. 834-848 , 2024

Link: https://doi.org/10.1158/..

2

Molecular targets of glucocorticoids that elucidate their t..:

Choi, Jaewoo ; Ceribelli, Michele ; Phelan, James D....
Cancer Cell. 42 (2024) 5 - p. 833-849.e12 , 2024

Link: https://doi.org/10.1016/..

3

Genomic binding of NF-Y in mouse and human cells:

Ronzio, Mirko ; Bernardini, Andrea ; Taglietti, Valentina...
Genomics. 116 (2024) 5 - p. 110895 , 2024

Link: https://doi.org/10.1016/..

4

IRF4 requires ARID1A to establish plasma cell identity in m..:

Bolomsky, Arnold ; Ceribelli, Michele ; Scheich, Sebastian...
Cancer Cell. 42 (2024) 7 - p. 1185-1201.e14 , 2024

Link: https://doi.org/10.1016/..

5

Comparative Assessment and High-Throughput Drug-Combination..:

Evsen, Lale ; Morris, Patrick J. ; Thomas, Craig J..
Pharmaceuticals. 16 (2023) 12 - p. 1635 , 2023

Link: https://doi.org/10.3390/..

6

mTOR inhibition overcomes RSK3-mediated resistance to BET i..:

Kumari, Anju ; Gesumaria, Lisa ; Liu, Yan-Jin...
JCI Insight. 8 (2023) 5 - p. , 2023

Link: https://doi.org/10.1172/..

7

High-throughput chemogenetic drug screening reveals PKC-Rho..:

Arang, Nadia ; Lubrano, Simone ; Ceribelli, Michele...
Cell Reports Medicine. 4 (2023) 11 - p. 101244 , 2023

Link: https://doi.org/10.1016/..

8

Preclinical Evaluation of the FGFR-Family Inhibitor Futibat..:

Wu, Jerry T. ; Cheuk, Adam ; Isanogle, Kristine...
Cancers. 15 (2023) 16 - p. 4034 , 2023

Link: https://doi.org/10.3390/..

9

Positional influence on cellular transcriptional identity r..:

Morse, David B. ; Michalowski, Aleksandra M. ; Ceribelli, Michele...
Cell Systems. 14 (2023) 6 - p. 464-481.e7 , 2023

Link: https://doi.org/10.1016/..

10

POSTER: MCL-349 Venetoclax, Ibrutinib, Prednisone, Obinutuz..:

Lakhotia, Rahul ; Pittaluga, Stefania ; Phelan, James...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S212 , 2023

Link: https://doi.org/10.1016/..

11

High-throughput approaches to uncover synergistic drug comb..:

Chory, Emma J. ; Wang, Meng ; Ceribelli, Michele...
SLAS Discovery. 28 (2023) 4 - p. 193-201 , 2023

Link: https://doi.org/10.1016/..

12

A landscape of response to drug combinations in non-small c..:

Nair, Nishanth Ulhas ; Greninger, Patricia ; Zhang, Xiaohu...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

MCL-349 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, an..:

Lakhotia, Rahul ; Pittaluga, Stefania ; Phelan, James...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S461 , 2023

Link: https://doi.org/10.1016/..

14

Oncogenic RAS commandeers amino acid sensing machinery to a..:

Yang, Yandan ; Bolomsky, Arnold ; Oellerich, Thomas...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

15

Publisher Correction: Oncogenic RAS commandeers amino acid ..:

Yang, Yandan ; Bolomsky, Arnold ; Oellerich, Thomas...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..